Does anyone have an idea how well Augment Bone Graft is doing now that it is FDA cleared? Is it winning the hearts and minds of the surgeons or is it a battle getting it used? What are the Value Analysis groups at the hospital level saying about price? Ask only because there appears to be little word about the progress.
Augment is doing poorly and heads are going to roll soon. I feel bad if you're in bio marketing. Especially if you're involved with this product. Better keep a box nearby. Only the paid surgeons are using it for the most part. Most hospitals are not going to pay the exorbitant costs that come with this product.
define "exorbitant". as compared to what? Looks like BP bought a flop here even with the approval from the fda.
Ought to be doing good, since this is the only thing the marketing d•ckheads care about. They're lettin everything else coast & go to h•ll.